Pharma News, 2019

Chinese government introduces initiative to enable generic drugs to enter market and reduce prices.

A unanimous vote by San Francisco's Board of Supervisors has effectively banned the sale of e-cigarettes in the city.

India’s Glenmark, a generic drug maker that intends to make a splash in the branded drug market, will later this year spin off the unit that will develop and manufacture its new drug offerings.

Sun Pharmaceutical has struggled to meet FDA expectations for the manufacturing lines at its key launch plant in Halol, India.

WALTHAM, Mass.

(Reuters) - Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control of the biggest name in medical aesthetics to help reduce its reli...

A new study by researchers at the University of Illinois suggests that three of the phenolic compounds in cocoa bean shells have powerful effects on the fat and immune cells in mice, potentially rever...

The European Commission has announced the approval of Pfizer’s Talzenna (talazoparib) for patients with inherited BRCA-mutated locally advanced or metatastatic breast cancer.

Sanofi and Regeneron have announced that the investigational IL-33 antibody REGN3500 (SAR440340) met its primary and secondary endpoints in the joint phase II proof-of-concept trial.

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq.

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease.

Opioids remain a mainstay of treatment for chronic and surgical pain, despite their side effects and risk for addiction and overdose.